Forleo M.D., Ph.D; Massimo Santini M.D Finally, controversy remains over safety issues, which, in the real world, excludes the vast majority of pacemaker patients from probably beneficial MRI ...

New pacing systems have recently been specifically designed by the major companies for safe use in the MRI environment (EnRhythm, Advisa, and Revo MRI SureScan pacemakers and CapSureFix MRI leads ...

The Revo MRI™ Pacing System with SureScan® technology has met the rigors of clinical evaluation, regulatory review, and FDA approval. Specifically Engineered for the MRI Environment ...

The feasible combination of leads and devices from different manufacturers leads to a loss of MRI-compatibility in every case. Thus far, only specially designated pacemaker systems from Medtronic ...

The new standard of care in pacing is to reduce unnecessary right ventricular pacing to as close to zero as possible. Mounting evidence suggests that right ventricular pacing is associated with a ...

The authors report on about an MRI-compatible pacemaker system and similar systems. This statement in this form is dangerous and requires clarification. The standards E-DIN 6877–1 and ASTM F2503 ...

Christensen, Clayton M. "We've Got Rhythm! Medtronic Corp.'s Cardiac Pacemaker Business (TN)." Harvard Business School Teaching Note 698-056, March 1998.

Robert Kowal, vice president of Medtronic’s cardiac pacing therapies. The blackout was front page news even before the child’s death was known. Newspaper coverage, including from the Pioneer ...

Imricor’s work over past 18 years developing the world’s only MRI-compatible devices for cardiac ablation procedures is ...

The U.S. FDA urged doctors and patients to use CT imaging if possible, when the MRI compatibility of any electronic implanted devices is unknown because problems with CT imaging are "extremely low" in ...

What's more, Medtronic, a medical device company, published an article with the title "Pets and pacemakers: best friends a while longer," about a miniature schnauzer that received a pacemaker ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...